Effects of the methoxy group in the side chain of debromoaplysiatoxin on its tumor-promoting and anti-proliferative activities

Ryo C. Yanagita, Hiroaki Kamachi, Masayuki Kikumori, Harukuni Tokuda, Nobutaka Suzuki, Kiyotake Suenaga, Hiroshi Nagai, Kazuhiro Irie

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Debromoaplysiatoxin (DAT) is a tumor promoter isolated from sea hare and exhibits anti-proliferative activity against several cancer cell lines. To clarify key residues that are responsible for its tumor-promoting activity, we focused on the chiral methoxy group in the side chain, whose role had not yet been discussed or examined before. Demethoxy-DAT (8) was derived from DAT and we evaluated its tumor-promoting activity, anti-proliferative activity, and ability to bind to protein kinase C (PKC) isozymes. Compound 8 showed somewhat weaker tumor-promoting activity than that of DAT both in vitro and in vivo, but showed higher anti-proliferative activity against several cancer cell lines. Although the affinity to novel PKC isozymes of 8 was comparable to that of DAT, the affinity to conventional PKC isozymes decreased slightly. These results suggest that the methoxy group of DAT is one of the key residues critical for tumor-promoting activity but not for anti-proliferative activity. Since the methoxy group has little influence on the molecular hydrophobicity, this is the first report showing that structural factors other than hydrophobicity in the side chain of DAT affected its biological activities.

Original languageEnglish
Pages (from-to)4319-4323
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume23
Issue number15
DOIs
Publication statusPublished - 2013 Aug 1

Fingerprint

Tumors
Neoplasms
Protein Kinase C
Isoenzymes
Hydrophobicity
Hydrophobic and Hydrophilic Interactions
Cells
Hares
Cell Line
Bioactivity
debromoaplysiatoxin
Oceans and Seas
Carcinogens

Keywords

  • Anti-proliferative activity
  • Aplysiatoxin
  • Cancer
  • Debromoaplysiatoxin
  • Protein kinase C
  • Tumor promotion

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Effects of the methoxy group in the side chain of debromoaplysiatoxin on its tumor-promoting and anti-proliferative activities. / Yanagita, Ryo C.; Kamachi, Hiroaki; Kikumori, Masayuki; Tokuda, Harukuni; Suzuki, Nobutaka; Suenaga, Kiyotake; Nagai, Hiroshi; Irie, Kazuhiro.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 23, No. 15, 01.08.2013, p. 4319-4323.

Research output: Contribution to journalArticle

Yanagita, Ryo C. ; Kamachi, Hiroaki ; Kikumori, Masayuki ; Tokuda, Harukuni ; Suzuki, Nobutaka ; Suenaga, Kiyotake ; Nagai, Hiroshi ; Irie, Kazuhiro. / Effects of the methoxy group in the side chain of debromoaplysiatoxin on its tumor-promoting and anti-proliferative activities. In: Bioorganic and Medicinal Chemistry Letters. 2013 ; Vol. 23, No. 15. pp. 4319-4323.
@article{f13cf98512e844a0a4ee8233349d5cae,
title = "Effects of the methoxy group in the side chain of debromoaplysiatoxin on its tumor-promoting and anti-proliferative activities",
abstract = "Debromoaplysiatoxin (DAT) is a tumor promoter isolated from sea hare and exhibits anti-proliferative activity against several cancer cell lines. To clarify key residues that are responsible for its tumor-promoting activity, we focused on the chiral methoxy group in the side chain, whose role had not yet been discussed or examined before. Demethoxy-DAT (8) was derived from DAT and we evaluated its tumor-promoting activity, anti-proliferative activity, and ability to bind to protein kinase C (PKC) isozymes. Compound 8 showed somewhat weaker tumor-promoting activity than that of DAT both in vitro and in vivo, but showed higher anti-proliferative activity against several cancer cell lines. Although the affinity to novel PKC isozymes of 8 was comparable to that of DAT, the affinity to conventional PKC isozymes decreased slightly. These results suggest that the methoxy group of DAT is one of the key residues critical for tumor-promoting activity but not for anti-proliferative activity. Since the methoxy group has little influence on the molecular hydrophobicity, this is the first report showing that structural factors other than hydrophobicity in the side chain of DAT affected its biological activities.",
keywords = "Anti-proliferative activity, Aplysiatoxin, Cancer, Debromoaplysiatoxin, Protein kinase C, Tumor promotion",
author = "Yanagita, {Ryo C.} and Hiroaki Kamachi and Masayuki Kikumori and Harukuni Tokuda and Nobutaka Suzuki and Kiyotake Suenaga and Hiroshi Nagai and Kazuhiro Irie",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.bmcl.2013.05.096",
language = "English",
volume = "23",
pages = "4319--4323",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "15",

}

TY - JOUR

T1 - Effects of the methoxy group in the side chain of debromoaplysiatoxin on its tumor-promoting and anti-proliferative activities

AU - Yanagita, Ryo C.

AU - Kamachi, Hiroaki

AU - Kikumori, Masayuki

AU - Tokuda, Harukuni

AU - Suzuki, Nobutaka

AU - Suenaga, Kiyotake

AU - Nagai, Hiroshi

AU - Irie, Kazuhiro

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Debromoaplysiatoxin (DAT) is a tumor promoter isolated from sea hare and exhibits anti-proliferative activity against several cancer cell lines. To clarify key residues that are responsible for its tumor-promoting activity, we focused on the chiral methoxy group in the side chain, whose role had not yet been discussed or examined before. Demethoxy-DAT (8) was derived from DAT and we evaluated its tumor-promoting activity, anti-proliferative activity, and ability to bind to protein kinase C (PKC) isozymes. Compound 8 showed somewhat weaker tumor-promoting activity than that of DAT both in vitro and in vivo, but showed higher anti-proliferative activity against several cancer cell lines. Although the affinity to novel PKC isozymes of 8 was comparable to that of DAT, the affinity to conventional PKC isozymes decreased slightly. These results suggest that the methoxy group of DAT is one of the key residues critical for tumor-promoting activity but not for anti-proliferative activity. Since the methoxy group has little influence on the molecular hydrophobicity, this is the first report showing that structural factors other than hydrophobicity in the side chain of DAT affected its biological activities.

AB - Debromoaplysiatoxin (DAT) is a tumor promoter isolated from sea hare and exhibits anti-proliferative activity against several cancer cell lines. To clarify key residues that are responsible for its tumor-promoting activity, we focused on the chiral methoxy group in the side chain, whose role had not yet been discussed or examined before. Demethoxy-DAT (8) was derived from DAT and we evaluated its tumor-promoting activity, anti-proliferative activity, and ability to bind to protein kinase C (PKC) isozymes. Compound 8 showed somewhat weaker tumor-promoting activity than that of DAT both in vitro and in vivo, but showed higher anti-proliferative activity against several cancer cell lines. Although the affinity to novel PKC isozymes of 8 was comparable to that of DAT, the affinity to conventional PKC isozymes decreased slightly. These results suggest that the methoxy group of DAT is one of the key residues critical for tumor-promoting activity but not for anti-proliferative activity. Since the methoxy group has little influence on the molecular hydrophobicity, this is the first report showing that structural factors other than hydrophobicity in the side chain of DAT affected its biological activities.

KW - Anti-proliferative activity

KW - Aplysiatoxin

KW - Cancer

KW - Debromoaplysiatoxin

KW - Protein kinase C

KW - Tumor promotion

UR - http://www.scopus.com/inward/record.url?scp=84879689027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879689027&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2013.05.096

DO - 10.1016/j.bmcl.2013.05.096

M3 - Article

VL - 23

SP - 4319

EP - 4323

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 15

ER -